Influence of continuous veno-venous hemofiltration on argatroban clearance in a patient with septic shock.
Schusterschitz
N
N
Bellmann
R
R
Stein
M
M
Dunzendorfer
S
S
Pechlaner
C
C
Joannidis
M
M
D000925:Anticoagulants / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001120:Arginine / Q000031:analogs & derivatives; D017809:Fatal Outcome; D005260:Female; D006440:Hemofiltration / Q000009:adverse effects*; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000150:complications*; D010875:Pipecolic Acids / Q000493:pharmacokinetics* / Q000627:therapeutic use; D012772:Shock, Septic / Q000150:complications* / Q000503:physiopathology; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000139:chemically induced / Q000150:complications*
D000925:Anticoagulants; D010875:Pipecolic Acids; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; C031942:argatroban